In-depth proteomics analysis of sentinel lymph nodes from individuals with endometrial cancer
| dc.contributor.author | Aboulouard, Soulaimane | |
| dc.contributor.author | Wisztorski, Maxence | |
| dc.contributor.author | Duhamel, Marie | |
| dc.contributor.author | Saudemont, Philippe | |
| dc.contributor.author | Cardon, Tristan | |
| dc.contributor.author | Narducci, Fabrice | |
| dc.contributor.author | Lemaire, Anne Sophie | |
| dc.contributor.author | Kobeissy, Firas H. | |
| dc.contributor.author | Leblanc, Éric | |
| dc.contributor.author | Fournier, Isabelle | |
| dc.contributor.author | SALZET, Michel | |
| dc.contributor.department | Biochemistry and Molecular Genetics | |
| dc.contributor.faculty | Faculty of Medicine (FM) | |
| dc.contributor.institution | American University of Beirut | |
| dc.date.accessioned | 2025-01-24T11:38:10Z | |
| dc.date.available | 2025-01-24T11:38:10Z | |
| dc.date.issued | 2021 | |
| dc.description.abstract | Endometrial cancer (EC) is one of the most common gynecological cancers worldwide. Sentinel lymph node (SLN) status could be a major prognostic factor in evaluation of EC, but several prospective studies need to be performed. Here we report an in-depth proteomics analysis showing significant variations in the SLN protein landscape in EC. We show that SLNs are correlated to each tumor grade, which strengthens evidence of SLN involvement in EC. A few proteins are overexpressed specifically at each EC tumor grade and in the corresponding SLN. These proteins, which are significantly variable in both locations, should be considered potential markers of overall survival. Five major proteins for EC and SLN (PRSS3, PTX3, ASS1, ALDH2, and ANXA1) were identified in large-scale proteomics and validated by immunohistochemistry. This study improves stratification and diagnosis of individuals with EC as a result of proteomics profiling of SLNs. © 2021 The Authors | |
| dc.identifier.doi | https://doi.org/10.1016/j.xcrm.2021.100318 | |
| dc.identifier.eid | 2-s2.0-85107931637 | |
| dc.identifier.pmid | 34195683 | |
| dc.identifier.uri | http://hdl.handle.net/10938/29000 | |
| dc.language.iso | en | |
| dc.publisher | Cell Press | |
| dc.relation.ispartof | Cell Reports Medicine | |
| dc.source | Scopus | |
| dc.subject | Alternative proteins | |
| dc.subject | Diagnosis | |
| dc.subject | Endometrial cancer | |
| dc.subject | Ghost proteome | |
| dc.subject | Protein mutations | |
| dc.subject | Proteomics | |
| dc.subject | Sentinel lymph nodes | |
| dc.subject | Aldehyde dehydrogenase, mitochondrial | |
| dc.subject | Amino acid sequence | |
| dc.subject | Annexin a1 | |
| dc.subject | Biomarkers, tumor | |
| dc.subject | C-reactive protein | |
| dc.subject | Endometrial neoplasms | |
| dc.subject | Female | |
| dc.subject | Gene expression profiling | |
| dc.subject | Gene expression regulation, neoplastic | |
| dc.subject | Humans | |
| dc.subject | Immunohistochemistry | |
| dc.subject | Lymph node excision | |
| dc.subject | Lymphatic metastasis | |
| dc.subject | Neoplasm grading | |
| dc.subject | Prognosis | |
| dc.subject | Prospective studies | |
| dc.subject | Sentinel lymph node | |
| dc.subject | Sentinel lymph node biopsy | |
| dc.subject | Serum amyloid p-component | |
| dc.subject | Signal transduction | |
| dc.subject | Survival analysis | |
| dc.subject | Trypsin | |
| dc.subject | Aldehyde dehydrogenase isoenzyme 2 | |
| dc.subject | Argininosuccinate synthase | |
| dc.subject | Ass1 protein | |
| dc.subject | Lipocortin 1 | |
| dc.subject | Pentraxin 3 | |
| dc.subject | Prss3 protein | |
| dc.subject | Serine proteinase | |
| dc.subject | Unclassified drug | |
| dc.subject | Aldh2 protein, human | |
| dc.subject | Anxa1 protein, human | |
| dc.subject | C reactive protein | |
| dc.subject | Prss3 protein, human | |
| dc.subject | Serum amyloid p | |
| dc.subject | Tumor marker | |
| dc.subject | Article | |
| dc.subject | Cancer grading | |
| dc.subject | Controlled study | |
| dc.subject | Endometrium cancer | |
| dc.subject | Human | |
| dc.subject | Human tissue | |
| dc.subject | Overall survival | |
| dc.subject | Protein analysis | |
| dc.subject | Protein expression | |
| dc.subject | Endometrium tumor | |
| dc.subject | Gene expression regulation | |
| dc.subject | Genetics | |
| dc.subject | Lymph node dissection | |
| dc.subject | Lymph node metastasis | |
| dc.subject | Metabolism | |
| dc.subject | Mortality | |
| dc.subject | Pathology | |
| dc.subject | Procedures | |
| dc.subject | Prospective study | |
| dc.subject | Surgery | |
| dc.title | In-depth proteomics analysis of sentinel lymph nodes from individuals with endometrial cancer | |
| dc.type | Article |
Files
Original bundle
1 - 1 of 1